Is Your Peptide Store Website FDA Aligned? onPoint Studio Web Design and Development Services BPC 157 for Foot Pain Houston Podiatrist Explains The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide FDA mulls compounding for peptides previously flagged over safety risks BioSpace Avoiding FDA Warning Letters: Why High Level Biodecontamination Is Essential in Pharma Manufacturing